AVASTIN (bevacizumab)

by GENENTECH

Dosages/Routes/Forms

Dosages/Routes/Forms
StrengthForm/RouteMarketing Status
100MGVIAL; INTRAVENOUS1
400MGVIAL; INTRAVENOUS1

Approval History

Efficacy Supplement with Clinical Data to Support
Labeling Revision
Labeling Revision
New or Modified Indication New or Modified Indication
Labeling Revision
Efficacy Supplement with Clinical Data to Support
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement